Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Fulvestrant × Clear all

NCT07570966 2026-05-06

Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Phase 1/2 Not yet recruiting

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05986071 2024-03-29

MATRIX

Phase 1/2 Not yet recruiting

Breast Neoplasms